Prone Positioning in Neurologically Deceased Potential Organ Donors to Improve Donor Lung Function and Lung Transplant Recipient Outcomes
P-POD
1 other identifier
interventional
40
1 country
1
Brief Summary
The purpose of this study is to determine the practicality of performing a future, large-scale study. The future study will look at the effect of mechanical ventilation in neurologically deceased (brain-dead) lung donors who are positioned to lay flat on their stomach (prone position), compared to donors who are positioned to lay flat on their back (supine position). The study will also look at the potential impact of prone positioning of the donor on transplant recipients of the study organs. The investigators are doing this study because the investigators want to increase the availability of donor lungs for lung transplant. Lung transplant is a life-saving treatment for individuals with lung disease, but there are not enough donated lungs to meet demand. Researchers are looking for better ways of preventing donated lungs from becoming unsuitable for transplant. Because of this, the goal of our study is to test whether prone positioning in neurologically deceased (brain-dead) lung donors can improve donor lung function and decrease complications, potentially increasing the number of donor lungs that can be used for transplant.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 6, 2024
CompletedFirst Posted
Study publicly available on registry
February 14, 2024
CompletedStudy Start
First participant enrolled
January 2, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2026
ExpectedDecember 4, 2024
December 1, 2024
7 months
February 6, 2024
December 3, 2024
Conditions
Outcome Measures
Primary Outcomes (3)
This pilot randomized controlled trial will assess the feasibility of conducting a future full randomized clinical trial, specifically, to determine whether donor accrual will be adequate (if we recruit 40 donors from 4 sites over 1 year)
The number of donors enrolled into the trial over 1 year to be placed into either prone positioning or supine positioning prior to lung transplant
90 days
To document adherence to the explicit prone positioning and mechanical ventilation protocol (if more than 80% of donors have no major protocol violations then considered adequate)
Number of major protocol violations, specifically: 1. Time from donation consent to randomization \> 3 hours; 2. Time from randomization to initiation of study assigned protocol \> 3 hours; 3. Time spent in prone positioning \< 50% of the total time from study consent to study termination
90 days
To document the number of those who cross over to the alternate strategy (if fewer than 10% of donors cross over to the alternate strategy, when not allowed by protocol then considered adequate)
The percentage of donors who cross over to the alternate strategy, when not allowed by protocol
90 days
Study Arms (2)
Protocolized protective mechanical ventilation in prone position
EXPERIMENTALProtocolized protective mechanical ventilation in supine position
NO INTERVENTIONInterventions
Prone Position: Study subjects randomized to the intervention group will be placed and maintained in prone position for at least 16 hours/day until the time of organ procurement or decline (typically 24-48 hours after donation consent) or the time that the lungs are declined for transplant.
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years
- Neurological determination of death at time of study entry
- Consent to organ donation
- Eligible for organ donation as confirmed by Trillium Gift of Life Network Coordinator
You may not qualify if:
- Open chest or abdominal wounds on the ventral body surface
- Absolute contraindication to lung transplantation on initial eligibility screening:
- Infection i. Positive HIV, HbsAg, Human T-lymphotropic virus-I/II test results ii. Positive West Nile Virus (WNV PCR) test results iii. Rabies diagnosis or within the last 6 months bitten by an animal proven to have rabies iv. Active endocarditis v. Active encephalitis or meningitis of unknown etiology vi. Active disseminated tuberculosis vii. Viral hemorrhagic fever including Ebola or known exposure to person with Ebola viii. COVID-19 presumptive or confirmed positive in the last 14 days
- Malignancy i. Donors with active cancer (donors receiving chemotherapy or radiation therapy or palliative cancer care within the last 5 years); excluding skin and primary brain tumors and prostate cancers.
- ii. Donors with a history of the following malignancies:
- Lung Cancer
- Choriocarcinoma
- Breast Cancer
- Colon Cancer within the last 10 years iii. Donors with active or past history of melanoma o Clinician decision that prone position is contraindicated
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Lorenzo delSorbolead
Study Sites (1)
Toronto General Hospital
Toronto, Ontario, M5G 2N2, Canada
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- MD, Critical Care Medicine Department, Toronto General Hospital
Study Record Dates
First Submitted
February 6, 2024
First Posted
February 14, 2024
Study Start
January 2, 2025
Primary Completion
August 1, 2025
Study Completion (Estimated)
August 1, 2026
Last Updated
December 4, 2024
Record last verified: 2024-12